Notes

The Catalyst research fund has a size of 0 as of 2026-09-23T13:45:20.437531+00:00 UTC. A news scan found the following headlines: TLX on Sun, 20 Sep 2026, about Telix and ITM joining forces, AVO on Tue, 08 Sep 2026, about Mission Produce's fiscal 2026 third quarter financial results, ABM on Tue, 22 Sep 2026, about ABM launching a technical training center, and ROIV on Wed, 23 Sep 2026, about Roivant announcing topline results of a proof of concept study for IMVT-1402. The fund also reviewed the following financial reports: UNFI's 10-K report on 2026-09-14, DRI's 10-K report on 2026-07-24, PPIH's 10-Q report on 2026-09-09, MRK's 10-Q report on 2026-08-07, and WLTH's 10-Q report on 2026-09-14. Additionally, the fund noted EPM's participation in upcoming investor conferences on Mon, 21 Sep 2026, and IPHA's 6-K report on 2026-09-17. The fund verified the following website hashes: KGF with hash 779e4855c061afea, ASKUL with hash e6f0d85c03a37ce6, IPHAnews with hash ef3293fd5ff26cb3, and SOBI with hash 7569409d160b2a08. The fund will preserve monitors 165, 168, 167, 137, and 22, and has no orders. The fund is for research only, and any strong or new information should be read in the originals and validated, while any weak, absent, or error information should be verified with cash and reverified. IPHA has a condition on Sep 17 and Sobi has a receipt conditional on Q1-2028.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 23, 2026, at 13:00:24 UTC. The fund is monitoring the following stocks: IONS, MIRM, GIS, and EAT, as well as CAG. The fund manager has reviewed the following SEC filings: IONS on September 23, MIRM on September 8, GIS on September 23, and EAT on September 17. A news scan found the headline 'Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease' on September 23. The GIS company had a conference on September 8 at 19:00 UTC, which has already passed. The fund manager will review the replay. On September 23, GIS released its morning earnings, with a Q&A session at 13:00 UTC, but the exact time of the first release is unknown. The fund manager will check the company's website for more information. The fund's baseline expectations for GIS are an EPS of $3.00-3.20 for the fiscal year 2027, with organic growth of -1.5% to +0.5%, and savings of $750 million. The fund manager has also reviewed EAT's investor day on September 17 and its upcoming earnings call on October 28. The fund's strategy for EAT is to record and validate stronger organic cash growth, and to reverify weaker or absent growth. The fund manager has not set any automatic trades and will review the full pipelines and early news for all stocks.

A fund manager for the Catalyst Research fund made some notes on September 23, 2026, at 12:30:28.580463 UTC. The fund has a size of 0 and is focused on research only. The manager reviewed some archived data from before September 11, 2008. The manager also looked at some recent data, including a news scan that found the headline 'Dave & Buster’s Reports Second Quarter 2026' on September 14, 2026, and a Securities and Exchange Commission, or SEC, filing for HITI on September 14, 2026. Another SEC filing was found for BFRI on the same day. The manager also reviewed some information about PLAY, TSM, and DATA.L S. Additionally, the manager noted some upcoming events, including a conference call for CAN on September 8, 2026, and a review of EGTX on September 11, 2026. The manager also found some information about BFRI's photodynamic therapy systems and a lifted suspension by the International Trade Commission, or ITC, on September 1, 2026. The manager reviewed a total of 11 panels of data, each with a unique identifier, or sha, and a preview of the content.

The Catalyst fund is for research only and has a size of 0. As of September 23, 2026, at 12:00:25 UTC, the fund manager reviewed the following information. The Securities and Exchange Commission filings for CHWY, ASO, and LOVE were reviewed, with links to their 10-Q filings on September 9 and 10, 2026. The SFIX 8-K filing from July 28, 2026, was also reviewed. Additionally, the fund manager looked at news releases from SAIL, KFY, and LOVE, with dates of September 22, September 9, and September 15, 2026, respectively. A Food and Drug Administration meeting for GRAL is scheduled for September 23, 2026. The fund manager noted that SEC filings may lag behind news and will review results on specific dates, including September 9, September 10, and September 24, 2026. The GRAL meeting on September 23 is a panel meeting, not an approval meeting. The fund manager will prioritize strong cash positions and reverify weak or absent ones, with no automatic orders placed.

The Catalyst research fund has a size of 0 as of 2026-09-23T09:30:23.503899+00:00 UTC. Recent news includes: TLX on Sun, 20 Sep 2026, about a partnership with ITM to create a radiopharmaceutical powerhouse, found at https://telixpharma.com/news-views/telix-and-itm-join-forces-to-create-a-radiopharmaceutical-powerhouse/. AVO announced fiscal 2026 third-quarter financial results on Tue, 08 Sep 2026, found at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial. ABM launched a technical training center on Tue, 22 Sep 2026, found at https://abm.gcs-web.com/news-releases/news-release-details/abm-launches-technical-training-center-help-meet-growing-demand. ROIV announced positive results from the Phocus study of mosliciguat on Tue, 08 Sep 2026, found at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. The fund also reviewed financial reports from UNFI, DRI, PPIH, MRK, and WLTH, with filing dates of 2026-09-14, 2026-07-24, 2026-09-09, 2026-08-07, and 2026-09-14 respectively. EPM announced participation in upcoming investor conferences on Mon, 21 Sep 2026, found at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-participate-upcoming-investor-conferences. IPHA filed a 6-K report on 2026-09-17, found at https://0001628280-26-062360/a6kseptember172026.htm. The fund verified the integrity of data from KGF, ASKUL, IPHAnews, and SOBI, with HTTP200 hash values of 779e4855c061afea, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 7569409d160b2a08 respectively. The fund decided to preserve monitors 165, 168, 167, and 137, and 22, and to take no orders, with a note to read originals and validate strong or new information, and to cash and reverify weak, absent, or error information, including IPHA news from Sep 17 and Sobi receipt conditional on Q1 2028.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 23, 2026, at 08:45:26 UTC. The fund is tracking several companies, including IONS, MIRM, GIS, and EAT, as well as CAG. The fund manager has reviewed SEC filings for IONS on September 4, MIRM on September 8, GIS on July 1, and EAT on September 17. A news scan found the headline 'Ionis to Seek Expedited FDA Review for ALS Drug' on September 22. GIS had a conference and review on September 8, and will have a morning earnings call on September 23, with a Q&A session at 13 UTC. The fund manager will review the earnings call, but the exact time of the first release is unknown. The baseline for GIS is an EPS of 3.00-3.20 for FY27, with organic growth of -1.5 to +0.5% and savings of 750m. The fund manager will verify the earnings call and review the results. EAT had an investor day on September 17, and will have an earnings call on October 28, with a review at 16:30 UTC. The fund manager will reverify the first news release. The fund is set to preserve 126, with an exit of 0.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 23, 2026, at 08:00:25 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager checked the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The manager also noted an FDA meeting on September 23, 2026, regarding GRAL. The manager will review the following: new morning results on September 9 at 12:30, LOVE on September 10 at 12:30, and SFIX on September 24 at 12:30 after the September 23 AMC. The GRAL panel on September 23 is not an approval. The manager will take the following actions: strong cash positions will be recorded and validated, while weak or early positions will be cashed out and reverified. No automatic orders will be placed.

The fund is called Catalyst Research and it is for research purposes only. The size of the fund is 0 and the time is 2026-09-23T05:15:30.817458+00:00 UTC. There are several news updates from various companies, including TLX on Sunday, September 20, 2026, AVO on Tuesday, September 8, 2026, ABM on Tuesday, September 22, 2026, and ROIV on Tuesday, September 8, 2026. Additionally, there are financial reports from UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 14, 2026. There is also an update from EPM on Monday, September 21, 2026, and a 6-K report from IPHA on September 17, 2026. The HTTP status codes for KGF, ASKUL, IPHAnews, and SOBI are all 200, with corresponding hashes. The research notes end with the instruction to preserve certain monitors and not to place any orders. The notes also mention that IPHA has a conditional receipt for Q1-2028 and that the sources and dates are listed in the job script and journal.

The Catalyst fund is currently in research mode only, with no active orders, as of September 23, 2026, at 04:30:35 UTC. The fund is tracking the following stocks: IONS, MIRM, GIS, and EAT, as well as CAG. The fund manager has reviewed SEC filings for IONS on September 4, MIRM on September 8, GIS on July 1, and EAT on September 17. A news scan found the headline 'Ionis to Seek Expedited FDA Review for ALS Drug' on September 22. GIS had a conference and review on September 8 at 19:40 UTC, which has already passed. The fund manager will review GIS's morning earnings on September 23 at 13:00 UTC. The baseline for GIS's fiscal year 2027 is an EPS of $3.00-3.20, with organic growth of -1.5% to +0.5% and savings of $750 million. The fund manager has also reviewed EAT's investor day on September 17 and will review its earnings call on October 28. The fund manager will verify the full pipelines and early news for these stocks. The fund is in research mode only, with no automatic trades, as of September 23, 2026, at 04:30:40 UTC.

A fund manager reviewed notes for the Catalyst Research fund, which has a size of 0 and compact receipts. The origins of the notes are in the PRE91108 archive, and the review was done on 2026-09-23T04:15:39.765708+00:00. The manager looked at various panels, including SEC filings for HITI and BFRI on 2026-09-14, a report from Dave & Buster's on September 14, 2026, and reviews of TSM and DATA.L S. The manager also reviewed information about EGTX, including a multifaceted news count and conferences on September 11 and 16. Additionally, the manager looked at information about BFRI, including an ITC photodynamic therapy systems components and a lifted suspension on September 1. The review consisted of 11 panels, and the manager was advised to read the originals before taking action.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 23, 2026, at 03:45:28 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager checked the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The manager also noted an upcoming FDA panel for GRAL on September 23, 2026. The manager will review the following results: new morning results on September 9 at 12:30, LOVE results on September 10 at 12:30, and SFIX results on September 24 at 12:30 after the September 23 AMC. The GRAL panel on September 23 is not an approval. The manager will use a strong cash position to record and validate results, and a weak or early position to cash and reverify. No automatic orders were placed.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0 and the time is 2026-09-23T01:15:26.727934+00:00 UTC. There are several news updates: TLX on Sunday, September 20, 2026, announced a partnership at https://telixpharma.com/news-views/telix-and-itm-join-forces-to-create-a-radiopharmaceutical-powerhouse/. AVO announced its fiscal 2026 third-quarter financial results on Tuesday, September 8, 2026, at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial. ABM launched a technical training center on Tuesday, September 22, 2026, at https://abm.gcs-web.com/news-releases/news-release-details/abm-launches-technical-training-center-help-meet-growing-demand. ROIV announced positive results from a study on Tuesday, September 8, 2026, at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. There are also several financial filings: UNFI filed a 10-K on September 14, 2026, DRI filed a 10-K on July 24, 2026, PPIH filed a 10-Q on September 9, 2026, MRK filed a 10-Q on August 7, 2026, and WLTH filed a 10-Q on September 14, 2026. EPM will participate in upcoming investor conferences, announced on Monday, September 21, 2026, at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-participate-upcoming-investor-conferences. IPHA filed a 6-K on September 17, 2026. The HTTP status is 200 for KGF, ASKUL, IPHAnews, and SOBI, with hashes 779e4855c061afea, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 7569409d160b2a08, respectively. The research is strong for new information and weak or absent for errors. IPHA has a conditional receipt for Q1 2028. The monitors for 165, 168, 167, 137, and 22 will be preserved. There are no orders and the sources and dates are in the job script and journal.

The Catalyst fund is for research only and has a size of 0. It is focused on the stocks IONS, MIRM, GIS, and EAT, as well as CAG. The fund manager has reviewed SEC filings for IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on September 17, 2026. A news scan found the headline 'Ionis to Seek Expedited FDA Review for ALS Drug' on September 22, 2026. GIS had a conference on September 8, 2026, at 19:40 UTC, which has already passed. The fund manager will review the replay. On September 23, 2026, GIS will release its morning earnings at 13:00 UTC, followed by a Q&A session. The fund manager will review the earnings release and Q&A session. If GIS has stronger organic cash flow and guidance, the fund manager will record and validate the results. If the results are weaker or absent, the fund manager will reverify the cash flow. The fund manager will not make any automatic entries and will only review the results on the designated dates. The baseline for GIS is an EPS of 3.00-3.20 for FY27, with organic growth of -1.5% to +0.5% and savings of 750 million. The fund manager has also reviewed EAT's investor day on September 17, 2026, and will review the earnings call on October 28, 2026. If EAT has stronger organic cash flow, the fund manager will record and validate the results. If the results are weaker or absent, the fund manager will reverify the cash flow. The fund manager will review the full pipelines and early news for all stocks.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 22, 2026, at 23:31:03 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager checked the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The manager also noted an upcoming FDA meeting for GRAL on September 23, 2026. The manager will review the SEC filings again on the following dates: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX. The GRAL panel meeting on September 23 is not an approval meeting. The manager will use a strong cash position to record and validate results, and a weak or early position to cash and reverify. No automatic orders were placed.

The Catalyst research fund has a size of 0 as of September 22, 2026, at 21:01:04 UTC. Recent news includes: TLX on September 20, 2026, about a partnership with ITM, AVO on September 8, 2026, about fiscal third-quarter financial results, ABM on September 22, 2026, about a new technical training center, and ROIV on September 8, 2026, about positive results from a study. The fund also reviewed financial reports from UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 14, 2026. Additionally, EPM announced participation in upcoming investor conferences on September 21, 2026, and IPHA filed a report on September 17, 2026. The fund checked the status of several websites, including KGF, ASKUL, IPHAnews, and SOBI, and found they were accessible. The fund will continue to monitor certain stocks, including 165, 168, 167, 137, and 22, and will not place any orders. The fund's research is for informational purposes only.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 22, 2026, at 20:16:06 UTC. The fund is tracking the stocks IONS, MIRM, GIS, and EAT, as well as CAG. A news scan found the headline 'Ionis to Seek Expedited FDA Review for ALS Drug' on September 22, 2026. The fund has noted the following SEC filings: IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on September 17, 2026. GIS had a conference and review on September 8, 2026, at 19:40 UTC, which has already passed. The fund is waiting for GIS's morning earnings on September 23, 2026, at 13:00 UTC. The baseline for GIS's FY27 EPS is 3.00-3.20, with organic growth of -1.5 to +0.5% and savings of 750 million. The fund has also noted EAT's investor day on September 17, 2026, and its upcoming earnings call on October 28, 2026. The fund's strategy for EAT is to record and validate stronger organic cash growth, and to reverify weaker or absent growth. The fund has not set any automatic trades and will reverify first news for EAT's earnings call. The fund's research is ongoing, with no orders currently placed, as of September 22, 2026, at 20:16:10 UTC.

A fund manager reviewed notes for the Catalyst Research fund, which has a size of 0 and compact receipts. The origins of the fund are in the PRE91108 archive, and the review was done on 2026-09-22T20:01:08.414581+00:00. The manager looked at various panels, including SEC filings for HITI and BFRI on 2026-09-14, and a report from Dave & Buster's on September 14, 2026. The manager also reviewed chosen UTC reviews, including one for TSM on September 10, and a new announcement from CAN on September 8. Additionally, the manager looked at information on EGTX, including a multifaceted news count and a conference schedule. The manager also reviewed information on BFRI, including an ITC ruling and a lifted suspension on September 1. The review consisted of 11 panels, and the manager advises reading the originals before taking action.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 22, 2026, at 19:16:03 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager checked the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The manager also noted an FDA meeting on September 23, 2026, regarding GRAL. The manager will review the SEC filings again on the following dates: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The GRAL panel on September 23 is not an approval. The manager will use a strong cash position to record and validate, and a weak or early position to cash and reverify. No automatic orders were placed.

The fund is called Catalyst Research and it has a size of 0 as of September 22, 2026, at 16:46:04 UTC. There are several news updates from various companies, including Telix Pharma on September 20, 2026, Mission Produce on September 8, 2026, ABM on September 22, 2026, Roivant on September 8, 2026, and Evolution Petroleum on September 21, 2026. Additionally, there are financial reports from UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, WLTH on September 14, 2026, and IPHA on September 17, 2026. The fund also checked the status of several websites, including KGF, ASKUL, IPHAnews, and SOBI, and found that they were all accessible with the given hash values. The fund will preserve its monitors and not place any orders. It is recommended to read the originals and validate the information, especially for strong or new updates, and to cash out and reverify for weak or absent updates.

A fund manager at Catalyst is researching stocks IONS, MIRM, GIS, and EAT, along with CAG, as of September 22, 2026, at 16:01:09 UTC. The manager has found the following SEC filings: IONS on September 4, MIRM on September 8, GIS on July 1, and EAT on September 17. A news scan found the headline 'Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets' on September 22. GIS had a conference on September 8, which has already passed. GIS is set to release earnings on September 23. The manager will review GIS's organic cash and guidance, and if it is stronger, will record and validate, but if it is weaker or absent, will reverify the cash. The baseline for GIS's FY27 EPS is 3.00-3.20, with organic growth of -1.5 to +0.5% and savings of 750 million. EAT had an investor day on September 17 and is set to have an earnings call on October 28. The manager will review EAT's organic cash and if it is stronger, will record and validate, but if it is weaker or absent, will reverify the cash. The manager will verify the full pipelines and early news for these stocks.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 22, 2026, at 15:16:03 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager checked the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The manager also noted an upcoming FDA meeting for GRAL on September 23, 2026. The manager will review the SEC filings again on the following dates: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The GRAL panel on September 23 is not for approval. The manager will use a strong cash position to record and validate results, and a weak or early cash position to cash and reverify results. No automatic orders were placed.

The fund is called Catalyst Research and it is for research purposes only. The size of the fund is 0 and the time of the update is 2026-09-22T12:31:05.884004+00:00. There are several news updates from various companies, including TLX on Sunday, September 20, 2026, from https://telixpharma.com/news-views/telix-and-itm-join-forces-to-create-a-radiopharmaceutical-powerhouse/, AVO on Tuesday, September 8, 2026, from https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tuesday, September 22, 2026, from https://abm.gcs-web.com/news-releases/news-release-details/abm-launches-technical-training-center-help-meet-growing-demand, ROIV on Tuesday, September 8, 2026, from https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. There are also several financial reports, including UNFI's 10-K report on September 14, 2026, DRI's 10-K report on July 24, 2026, PPIH's 10-Q report on September 9, 2026, MRK's 10-Q report on August 7, 2026, and WLTH's 10-Q report on September 14, 2026. Additionally, there are updates from EPM on Monday, September 21, 2026, from https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-participate-upcoming-investor-conferences, and IPHA's 6-K report on September 17, 2026. The HTTP status codes for KGF, ASKUL, IPHAnews, and SOBI are all 200, with hashes 779e4855c061afea, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 7569409d160b2a08, respectively. The research is strong for IPHA as of September 17, and there is a conditional receipt for Sobi for Q1 2028. The monitors for 165, 168, 167, 137, and 22 are to be preserved. The sources and dates are in the job script and journal. There are no orders.

A fund manager's notes were compiled on 2026-09-22T12:01:09.299998+00:00. The fund is called Catalyst Research, and it has a size of 0. The notes include compact receipts and origins from the PRE91108 archive. The notes are divided into 11 panels, each with a unique sha code, which is a type of digital fingerprint. The panels contain previews of various events and announcements, including SEC filings from HITI and BFRI on 2026-09-14, a report from Dave & Buster's on September 14, 2026, and a review of TSM on September 10. There are also mentions of EGTX, a company with 48 MFN count and a hash of 85e339a790c3, and its conferences on September 11 and 16. Additionally, there is a mention of BFRI's ITC and a lifted suspension on September 1. The notes end with a reminder to read the originals before taking action.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 22, 2026, at 11:46:05 UTC. The fund is monitoring the following stocks: IONS, MIRM, GIS, and EAT, as well as CAG. The fund manager has reviewed the following SEC filings: IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on September 17, 2026. A news scan found the headline that Barclays maintains an overweight rating on Ionis Pharmaceuticals and lowers its price target to $85 on September 9, 2026. The GIS company had a conference on September 8, 2026, at 19:00 UTC. The fund manager is waiting for the earnings report of GIS on September 23, 2026, at 13:00 UTC. The baseline expectations for GIS are an EPS of $3.00-3.20 and organic growth of -1.5% to +0.5%. The fund manager is also monitoring EAT, which had an investor day on September 17, 2026, and is scheduled to have an earnings call on October 28, 2026. The fund manager has decided not to make any automatic trades and will verify the full pipelines and early news for the following stocks: IONS, MIRM, GIS, and EAT. The fund is still in research mode only, with no orders, as of September 22, 2026, at 11:46:09 UTC.

The Catalyst fund is for research only and has a size of 0. As of September 22, 2026, at 11:16:04 UTC, the fund manager reviewed the following information. The Securities and Exchange Commission, or SEC, filings for CHWY, ASO, and LOVE were reviewed, with links to their 10-Q filings on September 9 and 10, 2026. The SFIX 8-K filing from July 28, 2026, was also reviewed. Additionally, the fund manager looked at news releases from SAIL, KFY, and LOVE, which were published on September 9 and 15, 2026. The FDA calendar was also checked for a meeting on September 23, 2026, regarding GRAL. The fund manager noted that SEC filings may lag behind news and that reviews will be done at 12:30 UTC on September 9 for new morning results, September 10 for LOVE, and September 24 for SFIX after the September 23 AMC. The GRAL panel on September 23 is not for approval. The fund manager will use strong cash to record and validate, and weak or early cash to reverify, with no automatic orders.